BEVACIZUMAB, PEMETREXED DISODIUM, AND CISPLATIN OR ERLOTINIB HYDROCHLORIDE AND BEVACIZUMAB IN TREATING PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER. A MULTICENTER PHASE II TRIAL INCLUDING BIOPSY AT PROGRESSION (BIO-PRO TRIAL).: